(Hypertension. 1996;27:235-244.)
© 1996 American Heart Association, Inc.
Articles |
Presented in part at the Southern and National Meetings of the American Federation of Clinical Research, New Orleans, La, January, 1990, and Washington, DC, May, 1990, and the American Society of Nephrology, Baltimore, Md, November, 1991, and published in abstract form (Clin Res. 1990;38:21A, Clin Res. 1990;38:428A, and J Am Soc Nephrol. 1991;2:475).
From the Divisions of Nephrology (W.R.F., D.W.P.) and Endocrinology (R.K.M.), Department of Medicine and Department of Pharmacology (A.A.J.), Medical University of South Carolina, Charleston, and the Ralph H. Johnson Veterans Affairs Medical Center (D.W.P., R.K.M.).
Correspondence to David W. Ploth, MD, Division of Nephrology, Department of Medicine, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC 29425-2220.
Abstract This study examined the role of endogenous kinins in the alteration of renal hemodynamics induced by low-dose converting enzyme inhibition in hydropenic normotensive rats and in the nonclipped kidney of hydropenic two-kidney, one clip hypertensive rats. Infusion of a bradykinin B2 receptor antagonist (D-Arg0,[Hyp3,Thi5,8,D-Phe7]-bradykinin, 1 or 10 µg · kg-1 · min-1) did not alter renal function of normotensive rats. In a second series of experiments, infusion of enalaprilat at 0.1 mg · kg-1 · h-1 increased renal blood flow (P<.01) and decreased renal vascular resistance (P<.01). The superimposition of the kinin antagonist at 1 µg · kg-1 · min-1 during the enalaprilat infusion decreased renal blood flow to a value similar to the preenalaprilat baseline and significantly different from the mean of the two enalaprilat periods before and after the addition of the kinin antagonistthe "mean effect of enalaprilat." The decrease in renal blood flow induced by the kinin antagonist was associated with an increase in renal vascular resistance above the mean effect of enalaprilat (P<.025). In two-kidney, one clip hypertensive rats, systemic infusion of enalaprilat augmented the hemodynamics of the nonclipped kidney by a degree similar to that in normotensive rats. In contrast to normotensive rats, superimposition of the kinin antagonist did not alter the enalaprilat-induced change in blood flow or vascular resistance of the nonclipped kidney. The results of this study suggest that endogenous kinins contribute to the increased renal function induced by low-dose converting enzyme inhibition in hydropenic normotensive rats but appear to contribute less to the enalaprilat-induced alterations of renal function in the nonclipped kidney of two-kidney, one clip hypertensive rats.
Key Words: angiotensin-converting enzyme inhibitors bradykinin enalapril hypertension, renovascular kinins vasodilation
This article has been cited by other articles:
![]() |
E. Dobrzynski, C. Wang, J. Chao, and L. Chao Adrenomedullin Gene Delivery Attenuates Hypertension, Cardiac Remodeling, and Renal Injury in Deoxycorticosterone Acetate-Salt Hypertensive Rats Hypertension, December 1, 2000; 36(6): 995 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, H. Yoshida, Q. Song, L. Chao, and J. Chao Enhanced renal function in bradykinin B2 receptor transgenic mice Am J Physiol Renal Physiol, March 1, 2000; 278(3): F484 - F491. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. MATSUDA, K. HAYASHI, K. ARAKAWA, M. NAITOH, E. KUBOTA, M. HONDA, A. MATSUMOTO, H. SUZUKI, T. YAMAMOTO, F. KAJIYA, et al. Zonal Heterogeneity in Action of Angiotensin-Converting Enzyme Inhibitor on Renal Microcirculation: Role of Intrarenal Bradykinin J. Am. Soc. Nephrol., November 1, 1999; 10(11): 2272 - 2282. [Abstract] [Full Text] |
||||
![]() |
M. J. ZYCHMA, J. GUMPRECHT, E. ZUKOWSKA-SZCZECHOWSKA, and W. GRZESZCZAK Polymorphisms in the Genes Encoding for Human Kinin Receptors and the Risk of End-Stage Renal Failure: Results of Transmission/DisequilibriumTest J. Am. Soc. Nephrol., October 1, 1999; 10(10): 2120 - 2124. [Abstract] [Full Text] |
||||
![]() |
K. Yayama, C. Wang, L. Chao, and J. Chao Kallikrein Gene Delivery Attenuates Hypertension and Cardiac Hypertrophy and Enhances Renal Function in Goldblatt Hypertensive Rats Hypertension, May 1, 1998; 31(5): 1104 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Frohlich Influence of Nitric Oxide and Angiotensin II on Renal Involvement in Hypertension Hypertension, January 1, 1997; 29(1): 188 - 193. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |